Short Summary
The PTAB denied Pharaoh Energy Services' petition to institute IPR proceedings against Flex-Chem for patent 9944843, citing a lack of compelling merits. The Board found that the cumulative weight of Fintiv factors and insufficient technical basis in the petitioner’s evidence led to the denial.
Detailed Summary
The Patent Trial and Appeal Board denied Pharaoh Energy Services' petition to institute IPR proceedings against Flex-Chem Holding Company and Flex-Chem Services Corporation regarding patent 9944843. Although the petitioner asserted grounds of anticipation (102) and obviousness (103) over prior art references Frenier and Reyes, the Board determined that the merits were not compelling enough to warrant institution under 35 U.S.C. § 314(a). The decision heavily relied on an analysis of the Fintiv factors, where the proximity of trial date and overlap with parallel district court litigation strongly favored denial. Furthermore, the Board found Petitioner's reliance on expert declarations was inadequate because they lacked technical depth regarding key limitations like 'nano-darcy shale formation.'
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Pharaoh Energy Services, LLC vs Flex-Chem Holding Company, LLC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsara, Inc.vsMotive Technologies, Inc.
The PTAB denied institution of an IPR proceeding (IPR2026-00034) involving Samsara, Inc. and Motive Technologies, Inc., finding the petitioner failed to meet the standard for likelihood of prevailing.
Imperative Care, Inc.vsInari Medical, Inc. et al.
Imperative Care’s petition to invalidate Inari Medical’s hemostasis valve patent was granted. The Board found a reasonable likelihood of success on anticipation and obviousness grounds and instituted review of all nine claims.
Samsung Austin Semiconductor, LLC et al.vsSung, Chien-Min
Samsung Austin Semiconductor challenges the '802 Patent covering Chemical Mechanical Planarization (CMP) pad dressing technology. The Petitioner argues that prior art references, including Tsai et al., anticipate or render obvious all 21 claimed claims. This is a foundational challenge to the patent's validity in semiconductor manufacturing.
Biofrontera Incorporated et al.vsSun Pharmaceutical Industries, Inc.
The PTAB found all challenged claims unpatentable by a preponderance of the evidence. The Petitioner successfully argued that combining prior art references (Lundahl and Larsen) rendered the illuminator system obvious to a Person Having Ordinary Skill in the Art (POSITA).
Google LLC et al.vsMullen Industries LLC
Google and Samsung petition the PTAB to rehear the Director's discretionary denial of institution for IPR2025-00227, arguing the denial exceeds statutory authority and misapplies the "settled expectations" doctrine.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.